Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise | 18 | 2024 | 5890 | 1.350 |
Why?
|
Proteomics | 10 | 2024 | 3849 | 1.130 |
Why?
|
Blood Proteins | 4 | 2024 | 1173 | 0.750 |
Why?
|
Keto Acids | 1 | 2019 | 35 | 0.670 |
Why?
|
Guanidines | 1 | 2019 | 194 | 0.620 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15500 | 0.620 |
Why?
|
Heart Failure | 9 | 2024 | 11669 | 0.570 |
Why?
|
Proteome | 3 | 2022 | 1862 | 0.570 |
Why?
|
Cardiovascular System | 1 | 2023 | 834 | 0.510 |
Why?
|
Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.510 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 360 | 0.460 |
Why?
|
Metabolomics | 7 | 2023 | 1659 | 0.410 |
Why?
|
Physical Endurance | 3 | 2023 | 366 | 0.350 |
Why?
|
Blood Pressure | 2 | 2024 | 8481 | 0.350 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12690 | 0.290 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1388 | 0.280 |
Why?
|
Exercise Test | 2 | 2024 | 2127 | 0.270 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2021 | 851 | 0.250 |
Why?
|
Atherosclerosis | 1 | 2021 | 3408 | 0.250 |
Why?
|
Cardiology | 1 | 2016 | 1656 | 0.250 |
Why?
|
Vitamin D | 2 | 2016 | 3303 | 0.240 |
Why?
|
Patient Compliance | 1 | 2015 | 2690 | 0.240 |
Why?
|
Stroke Volume | 4 | 2024 | 5496 | 0.240 |
Why?
|
Hypertension | 1 | 2024 | 8540 | 0.230 |
Why?
|
Body Composition | 3 | 2024 | 2426 | 0.220 |
Why?
|
Coronary Vessels | 1 | 2015 | 3096 | 0.220 |
Why?
|
Insulin Resistance | 3 | 2023 | 3963 | 0.220 |
Why?
|
Heart Diseases | 1 | 2016 | 2781 | 0.220 |
Why?
|
Oxygen Consumption | 4 | 2023 | 1866 | 0.210 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5127 | 0.210 |
Why?
|
Blood Glucose | 4 | 2023 | 6391 | 0.200 |
Why?
|
Resistance Training | 1 | 2024 | 193 | 0.190 |
Why?
|
Health Status | 1 | 2015 | 4077 | 0.190 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 63 | 0.190 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3627 | 0.180 |
Why?
|
Metabolic Networks and Pathways | 2 | 2021 | 789 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2022 | 542 | 0.160 |
Why?
|
Humans | 39 | 2024 | 761504 | 0.160 |
Why?
|
Incidence | 6 | 2024 | 21353 | 0.150 |
Why?
|
Lactic Acid | 1 | 2022 | 1139 | 0.140 |
Why?
|
Coronary Disease | 2 | 2022 | 5914 | 0.140 |
Why?
|
Exercise Tolerance | 1 | 2022 | 836 | 0.140 |
Why?
|
Hungary | 1 | 2016 | 82 | 0.140 |
Why?
|
Adaptation, Physiological | 1 | 2023 | 1301 | 0.130 |
Why?
|
Echocardiography | 4 | 2024 | 4989 | 0.130 |
Why?
|
Dyspnea | 1 | 2024 | 1347 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12148 | 0.120 |
Why?
|
Electronic Health Records | 2 | 2024 | 4811 | 0.120 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 740 | 0.120 |
Why?
|
Intra-Abdominal Fat | 1 | 2019 | 613 | 0.110 |
Why?
|
Glucose | 2 | 2023 | 4346 | 0.110 |
Why?
|
Muscle, Skeletal | 3 | 2023 | 4948 | 0.110 |
Why?
|
Data Mining | 1 | 2018 | 551 | 0.110 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2015 | 241 | 0.110 |
Why?
|
Middle Aged | 17 | 2024 | 220895 | 0.110 |
Why?
|
Metabolic Diseases | 1 | 2019 | 683 | 0.100 |
Why?
|
Adult | 16 | 2024 | 221177 | 0.100 |
Why?
|
Male | 20 | 2024 | 360804 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14605 | 0.100 |
Why?
|
Risk | 3 | 2021 | 9610 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1902 | 0.090 |
Why?
|
Aged | 12 | 2024 | 169289 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1567 | 0.090 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2024 | 273 | 0.090 |
Why?
|
Female | 19 | 2024 | 392644 | 0.090 |
Why?
|
Heart | 1 | 2023 | 4404 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3879 | 0.090 |
Why?
|
Life Style | 1 | 2021 | 3917 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12463 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1723 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2767 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26125 | 0.070 |
Why?
|
Obesity | 3 | 2024 | 12947 | 0.070 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 1578 | 0.070 |
Why?
|
Cholesterol, HDL | 2 | 2024 | 1814 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6403 | 0.060 |
Why?
|
Peptide Fragments | 3 | 2024 | 5112 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1188 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5840 | 0.060 |
Why?
|
Self Report | 1 | 2015 | 3724 | 0.050 |
Why?
|
Metabolome | 2 | 2022 | 989 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 1533 | 0.050 |
Why?
|
Health Behavior | 1 | 2015 | 2643 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2243 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Risk Factors | 4 | 2024 | 74206 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3415 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2024 | 326 | 0.050 |
Why?
|
Homoarginine | 1 | 2021 | 9 | 0.050 |
Why?
|
Orotic Acid | 1 | 2021 | 24 | 0.050 |
Why?
|
Biology | 1 | 2023 | 290 | 0.050 |
Why?
|
Cohort Studies | 3 | 2024 | 41487 | 0.050 |
Why?
|
Spermine | 1 | 2021 | 70 | 0.050 |
Why?
|
Uridine | 1 | 2021 | 141 | 0.040 |
Why?
|
Polyamines | 1 | 2021 | 133 | 0.040 |
Why?
|
Adipokines | 1 | 2022 | 310 | 0.040 |
Why?
|
Cystatin C | 1 | 2021 | 269 | 0.040 |
Why?
|
Muscle Strength | 1 | 2024 | 624 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 676 | 0.040 |
Why?
|
Proline | 1 | 2021 | 457 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2021 | 416 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 54425 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 960 | 0.040 |
Why?
|
Mississippi | 1 | 2017 | 95 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39106 | 0.040 |
Why?
|
Calcium Signaling | 1 | 2021 | 733 | 0.040 |
Why?
|
Exercise Therapy | 1 | 2024 | 929 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.030 |
Why?
|
Research Design | 2 | 2024 | 6180 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2116 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6374 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1740 | 0.030 |
Why?
|
Diuretics | 1 | 2018 | 610 | 0.030 |
Why?
|
Phenotype | 2 | 2023 | 16591 | 0.030 |
Why?
|
United States | 3 | 2022 | 72334 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2018 | 983 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2418 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2018 | 928 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 909 | 0.030 |
Why?
|
Collagen | 1 | 2021 | 2638 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22170 | 0.020 |
Why?
|
Homeostasis | 1 | 2023 | 3323 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2021 | 2135 | 0.020 |
Why?
|
Hemodynamics | 1 | 2022 | 4159 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 59243 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3518 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1162 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2176 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 3028 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6596 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10552 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15732 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81525 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5821 | 0.020 |
Why?
|
Animals | 3 | 2023 | 168459 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58976 | 0.010 |
Why?
|
Child | 2 | 2024 | 80153 | 0.010 |
Why?
|
Adolescent | 2 | 2024 | 88319 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15936 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23995 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 39967 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23445 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20098 | 0.010 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_